9 01, 2024

Nurturing Complexity: The role of vascularization in Organoid Advancements

2024-01-09T11:27:37+00:00January 9th, 2024|Blog, organoid news|

Organoids are exciting models that are rapidly becoming a hopeful platform for many medical advances such as drug screening and disease modeling. However, due to a lack of vascularization, they have limitations for future applications. This review blog summarizes several practical methods for successful organoid vascularization to date.

6 12, 2023

Considerations for the use of high-purity recombinant growth factors in cellular agriculture applications

2024-01-05T13:37:53+00:00December 6th, 2023|Blog, cellular agriculture|

Cultivated meat is a nascent industry with a developing regulatory framework, with distinct regional differences. There are however some shared themes across regulatory frameworks and best practice. Within the UK and EU, cultivated meat is considered a novel food and as such falls under the scope of Regulation (EU) No. 2015/2283. In response to this classification, the Food Safety Agency commissioned an internal report into the potential hazards to the consumer associated with the production and consumption of cultured meat. Following a literature review of 154 papers discussing cultured meat as a technology, themes that apply to growth factors have been highlighted and discussed.

30 11, 2023

Hepatocyte-derived organoids provide unique insights into liver cell invasion by malaria parasites

2024-01-05T13:39:37+00:00November 30th, 2023|Blog, organoid news|

Complex 3D liver models that more closely mimic human biology open opportunities for improved drug and vaccine discovery for malaria and related parasitic diseases.

21 07, 2023

My first ISSCR – sharing is power – Sveva Bottini shares her experience of ISSCR 2023

2023-07-21T09:58:18+00:00July 21st, 2023|Blog, cellular agriculture, Event|

In this personal blog piece, Sveva Bottini from the Bertero Lab in Turin, shares her experiences of ISSCR 2023 in Boston. During the event, Qkine was proud to co-sponsor a poster abstract by Sveva on ‘Optimization of growth factors for human pluripotent stem cell culture in basal 8 media.’

2 05, 2023

New phase of growth as Qkine relocates into state-of-the-art facility

2023-05-05T10:36:49+00:00May 2nd, 2023|Blog, News|

New phase of growth as Qkine relocates into state-of-the-art facility A Q&A with Dr. Andy Day, Head of Product Development and Manufacture at Qkine Qkine is entering the next phase of commercial growth, having secured the lease on 1 Murdoch House, based in Cambridge city centre, last year. [...]

2 04, 2023

Cardiac organoids – the future of drug discovery?

2023-04-04T08:21:38+00:00April 2nd, 2023|Blog, organoid news|

Despite advances in research, around 90% of drugs fail during phase 1 clinical trials. New drugs for the treatment of cardiovascular disease and oncology have a particularly high failure rate, largely attributed to cardiotoxicity...

22 02, 2023

Protein origami to change the future of food

2023-02-22T14:25:34+00:00February 22nd, 2023|Blog, cellular agriculture|

Are you looking for an idea to start a multimillion-pound business? Proteins that stimulate cell growth currently cost several million pounds per gram, which makes them more expensive than diamonds. You need particularly lots of them if you want to grow enough cells to assemble a steak. This so-called ‘cultivated’ or ‘lab-grown’ meat was initially proposed as food for astronauts but has since turned from a science fiction fantasy to a source of hope for a more sustainable and animal welfare-conscious food for the world.

8 12, 2022

Designing biomimetic neural materials for scalable 3D cell culture

2023-02-24T10:34:38+00:00December 8th, 2022|Blog, News|

In conjunction with the LifETIME CDT program, Qkine has sponsored a PhD studentship based at Aston University, Birmingham, UK. Martha Gallagher started her PhD in Professor Eric Hill’s lab to develop a 3D biomaterial scaffold that will display multiple neurodevelopmental signalling factors to mimic corticogenesis with induced pluripotent stem cell-derived neurons and glia.


Go to Top